Journal of Osteoporosis / 2011 / Article / Tab 2

Clinical Study

Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy

Table 2

BMD and FRAX stratified by presence of vertebral fracture.

No vertebral fracture Vertebral fracture
n = 56n = 22
VariableMedianMeanSDRangeMedianMeanSDRangeP-value*

BMD, femoral neck0.70.70.10.5–1.00.70.70.10.5–0.90.34
T score, femoral neck−1.8−1.90.7−3.3–−0.7−2.2−2.00.8−3.4–−0.60.33
BMD, total hip0.90.90.10.6–1.20.80.80.20.5–1.20.22
T score, total hip−1.2−1.30.9−3.0–0.3−1.4−1.51.1−3.7–0.00.51
BMD, lumbar spine1.01.00.20.8–1.60.90.90.20.5–1.30.11
T score, lumbar spine−1.1−0.91.6−4.0–4.6−1.8−1.61.8−5.2–2.10.10
FRAX (Osteo) without BMD (%)9.310.86.21.8–33.015.016.06.86.8–31.00.001
FRAX (Hip) without BMD (%)4.05.54.80.1–24.06.88.16.01.7–25.00.03
FRAX (Osteo) with BMD (%)7.59.56.91.9–33.011.014.07.85.4–41.00.002
FRAX (Hip) with BMD (%)3.04.55.10.1–28.04.56.67.11.1–36.00.03

* P values are from the Wilcoxon rank sum test.
BMD measurements are in g/cm2.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.